102 Delegation of Responsibilities
| Document Name: Delegation of Responsibilities | Document Number: 102 | Revision Date: 11JUN2024 | Supersedes: 102.00 |
| Target Group: Research Personnel | Approval Date: 20Dec2024 | Effective Date: 01Jan2025 | Training Required: -Human Subjects Protection (HSP) -Good Clinical Practice (GCP) |
Purpose
To ensure the Principal Investigator (PI) and all research team members assisting with the conduct of clinical research at the Ohio University Heritage College of Osteopathic Medicine’s Clinical and Translational Research Unit (CTRU) are informed about their obligations and responsibilities as they pertain to Good Clinical Practices (GCP), the investigational plan, applicable regulations, and institutional policies.
This Standard Operating Procedure (SOP) describes the responsibilities of the PI and the procedures for identifying and delegating specific responsibilities to research team members for conducting clinical research. Attachment templates include:
A: Delegation of Authority (DOA) Log, B: Study Team Training Log
Responsibilities
The CTRU is responsible for developing, implementing, and maintaining SOPs. Creating new or revising an existing SOP is determined by changes to federal regulations, guidelines, institutional policies, or procedures. All applicable documents will be provided to departments and research teams conducting human subject research.
Procedures
1. Investigator Responsibilities:
- The PI will conduct and/or supervise the clinical research study to ensure it is conducted according to the IRB-approved protocol, institutional policies, GCP, and applicable regulations.
- The PI is ultimately responsible for conducting the study but may delegate tasks to qualified research personnel when appropriate.
- Maintain a list of appropriately qualified persons to whom the investigator has delegated significant study-related duties will be maintained (See Attachment A: Delegation of Authority Log).
- Ensure all persons assisting with the research study are adequately trained on the protocol, investigational product(s), and study-related duties and functions (See Attachment B: Study Team Training Log).
- Ensure all individuals involved in study-related duties are approved by the IRB.
- Conduct study activities only after IRB approval and in accordance with the approved protocol, and ensure all regulatory requirements are fulfilled.
- Implement modifications in approved research only after review and approval of the modifications by the IRB.
- Be aware of and comply with GCP, applicable regulatory requirements, and institutional policies and procedures.
2. Research Coordinator Responsibilities:
- Each clinical research study will have a designated research coordinator who performs and/or oversees the research as delegated by the PI.
- Conduct the clinical research study to ensure it is conducted according to the IRB-approved protocol, institutional policies, GCP, and applicable regulations.
- Design and maintain organizational tools to conduct the study accurately and comply with GCP.
- Ensure the safety and welfare of the study subjects.
- Train other site personnel in understanding and implementing the protocol.
- Recruit and screen the potential study subjects according to the protocol's inclusion and exclusion criteria.
- Obtain proper written informed consent from each study subject before participation in the study
- Assign study subject numbers, schedule study subjects' visits, and perform delegated activities of the study completely and accurately.
- Report all adverse events to the PI.
- Maintain adequate and accurate case histories for each study subject that record all observations and data during the study.
- Complete the Case Report Forms (CRFs) for the study accurately and completely.
- Maintain accurate and complete records of the receipt, dispensing, and return of all clinical supplies and note all discrepancies.
- Maintain all required documentation in the study documentation file.
- Communicate with the Sponsor regarding study activities as necessary.
- Meet with the Sponsor's representatives to discuss the conduct of the study and review study data.
3. Procedure for Delegation of Research Responsibilities:
- The PI assumes the authority and responsibility for the conduct of a clinical research study. However, the PI has the authority to delegate responsibilities to individual research team members, if appropriate.
- The PI may select Sub-Investigators with appropriate education and training to ensure the investigation is conducted according to the signed investigator statement, the investigational plan, GCP, institutional policies, and applicable regulations.
- The PI may determine the appropriate delegation of authority to specific research team members for each clinical research study conducted at this investigational site.
- Delegation of specific responsibilities will be documented appropriately and kept on file with the regulatory documents for each clinical research study (See Attachment A: Delegation of Authority Log). Study team members who have significant trial-related duties as determined by the PI will be listed on the DOA log.
- All members of the research team who are delegated specific responsibilities should communicate regularly with the PI to ensure he/she is informed in a timely manner of all study-related activities.
Applicable Regulations, Guidance, and Policies
| Regulation | Title |
|---|---|
| 21 CFR 50 | Protection of Human Subjects |
| 21 CFR 312 | Investigational New Drug Application |
| 21 CFR 812 | Investigational Device Exemptions |
| 45 CFR 46 | Protection of Human Subjects |
| ICH E6(R2) | Guideline for Good Clinical Practice E6 Integrated Addendum |
| FDA Guidance for Industry | Investigator Responsibilities – Protecting the Rights, Safety, and Welfare of Study Subjects, October 2009 |
References: None
Attachments: A: Delegation of Authority Log, B: Study Team Training Log
Appendices: None
Approver: Director, CTRU and Clinical Partnerships